Diovan for paediatric use

Diovan (valsartan) 40mg and 320mg tablets have had their licences extended to include treatment of hypertension in children and adolescents, 6 to 18 years of age.

Use of Diovan for this indication is extensively monitored by the Commission on Human Medicines (CHM) and the Medicines and Healthcare products Regulatory Agency (MHRA) and any adverse reactions should be reported when prescribed to children or adolescents with hypertension.

View Diovan drug record

Further information: Novartis

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Skin cancer warning for actinic keratosis treatment

Skin cancer warning for actinic keratosis treatment

Patients treated with ingenol mebutate (Picato) should...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

Drug shortages - live tracker

Drug shortages - live tracker

Added: Accupro, Dermovate, Norinyl-1.
Use our...

Anti-Anginal Preparations, Summary by Pharmacological Class

Anti-Anginal Preparations, Summary by Pharmacological Class

Available formulations of anti-anginal drugs.